FAKTOR-OPTIONSSCHEIN - TANDEM DIABETES CARE Stock

Certificat

DE000MG23M23

Market Closed - Börse Stuttgart 15:39:54 2024-06-25 EDT
10.56 EUR +4.97% Intraday chart for FAKTOR-OPTIONSSCHEIN - TANDEM DIABETES CARE
Current month-79.61%
1 month-74.99%
Date Price Change
24-06-25 10.56 +4.97%
24-06-24 10.06 -34.29%
24-06-21 15.31 +0.86%
24-06-20 15.18 -4.17%
24-06-19 15.84 +1.34%

Delayed Quote Börse Stuttgart

Last update June 25, 2024 at 03:39 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying TANDEM DIABETES CARE, INC.
Issuer Morgan Stanley
WKN MG23M2
ISINDE000MG23M23
Date issued 2024-04-10
Strike 31.99 $
Maturity Unlimited
Parity 0.73 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 51.86
Lowest since issue 5.79
Spread 0.19
Spread %1.77%

Company Profile

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Sector
-
More about the company

Ratings for Tandem Diabetes Care, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Tandem Diabetes Care, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
40.15 USD
Average target price
49.93 USD
Spread / Average Target
+24.37%
Consensus